Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer - Safi, Seyer; Yamauchi, Yoshikane; Hoffmann, Hans; Weichert, Wilko; Jost, Philipp J.; Winter, Hauke; Muley, Thomas; Beckhove, Philipp (Cancers, 2020)
Gesehen am 03.03.2022